Blog

Apr 4, 2020

No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection

Posted by in category: biotech/medical

We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.

Copyright © 2020 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered trademark of Elsevier B.V.

ScienceDirect ® is a registered trademark of Elsevier B.V.

Leave a reply